GenBody

팝업레이어 알림

팝업레이어 알림이 없습니다.

Rapid Diagnostics Test kits (RDT)

COVID-19 Ag Saliva Test

Immunochromatographic assay for the qualitative detection of SARS-CoV-2 antigen in human saliva specimen

6f8106912464aecd016193e2c4fdafa4_1708329159_45.png

Product features
  • Getting results In 20 minutes
  • Simple and easy to use
  • Optimized for Point of Care with a small diagnostic kit 
  • No need to use extra reader
  • High diagnostic accuracy
  • Economical and capable of mass testing
  •  Specification

    Specimen Saliva
    Specimen volume 200㎕
    Test time 15~20 minutes
    Storage temperature 2-30℃
    Expiration date Refer to label for expiration date



  • The COVID-19 disease caused by SARS-CoV-2 is a new respiratory epidemic and was declared "pandemic" by the World Health Organization (WHO), the World Health Organization, in March 2020. Symptoms of this epidemic vary, but are mainly fatigue, high fever, cough, and in more severe cases, breathing problems and severe lung damage. Although molecular diagnostics are the standard diagnostic method for COVID-19, rapid antigen testing, which is simple, convenient, and ready to be tested in the field, has been widely used in quarantine in most developed countries, including the United States, Japan, and Europe, due to various constraints (dependence on accuracy by gene extraction technology, longer than six hours of analysis, expensive analytical equipment, and highly trained professionals).